Human cannabinoid pharmacokinetics.
作者信息
Huestis Marilyn A
机构信息
Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, NIH, 5500 Nathan Shock Drive, Baltimore, MD 21146, USA.
出版信息
Chem Biodivers. 2007 Aug;4(8):1770-804. doi: 10.1002/cbdv.200790152.
Abstract
摘要
相似文献
1
Human cannabinoid pharmacokinetics.
Chem Biodivers. 2007 Aug;4(8):1770-804. doi: 10.1002/cbdv.200790152.
2
Electrochemical Sensing of Cannabinoids in Biofluids: A Noninvasive Tool for Drug Detection.
ACS Sens. 2020 Mar 27;5(3):620-636. doi: 10.1021/acssensors.9b02390. Epub 2020 Mar 18.
3
[Passive inhalation of cannabis smoke--is it detectable?].
Tidsskr Nor Laegeforen. 2009 Jan 15;129(2):109-13. doi: 10.4045/tidsskr.09.33889.
4
The Pharmacokinetics and Pharmacodynamics of a Hemp-Derived "Full-Spectrum" Oral Cannabinoid Product with a 1:1 Ratio of Cannabidiol to Cannabidiolic Acid and Delta-9-Tetrahydrocannabinol to Delta-9-Tetrahydrocannabinolic Acid: A Double-Blind, Placebo-Controlled, Within-Subjects Human Laboratory Study.
Cannabis Cannabinoid Res. 2025 Apr;10(2):e299-e313. doi: 10.1089/can.2024.0187. Epub 2025 Mar 5.
5
Effects of lipophilicity and functional groups of synthetic cannabinoids on their blood concentrations and urinary excretion.
Forensic Sci Int. 2020 Feb;307:110106. doi: 10.1016/j.forsciint.2019.110106. Epub 2019 Dec 18.
6
Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
Clin Chem. 2016 Dec;62(12):1579-1592. doi: 10.1373/clinchem.2016.263475. Epub 2016 Oct 10.
7
Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts.
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 1;850(1-2):515-22. doi: 10.1016/j.jchromb.2006.12.045. Epub 2007 Jan 11.
8
Preliminary pharmacokinetic and psychophysical investigations after controlled oral and inhalative consumption of hexahydrocannabinol (HHC).
Sci Rep. 2025 Mar 24;15(1):10086. doi: 10.1038/s41598-025-93931-4.
9
An evaluation of a homogeneous enzyme immunoassay (EMIT) for cannabinoid detection in biological fluids.
J Forensic Sci Soc. 1982 Jul;22(3):275-81. doi: 10.1016/s0015-7368(82)71490-2.
10
High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.
Int J Legal Med. 2015 Nov;129(6):1233-45. doi: 10.1007/s00414-015-1257-4. Epub 2015 Sep 8.
引用本文的文献
1
A Meta-Narrative Review of Channelopathies and Cannabis: Mechanistic, Epidemiologic, and Forensic Insights into Arrhythmia and Sudden Cardiac Death.
Int J Mol Sci. 2025 Sep 4;26(17):8635. doi: 10.3390/ijms26178635.
2
Cannabidiol from L. Herbal Extract as an Bioactive Factor in Polysaccharide Coatings with Antioxidant Properties for Extended Food Quality.
Materials (Basel). 2025 Aug 31;18(17):4081. doi: 10.3390/ma18174081.
3
Cannabis impacts female fertility as evidenced by an in vitro investigation and a case-control study.
Nat Commun. 2025 Sep 9;16(1):8185. doi: 10.1038/s41467-025-63011-2.
4
Analysis of six CYP450 genetic variants regarding the response to cannabidiol combined with anticonvulsant medication in mexican patients with drug-resistant epilepsy.
Front Pharmacol. 2025 Aug 21;16:1626054. doi: 10.3389/fphar.2025.1626054. eCollection 2025.
5
Cannabis use is associated with changes in psychological and functional well-being during young adulthood: evidence from self-reports and hair analyses.
Psychol Med. 2025 Aug 26;55:e246. doi: 10.1017/S003329172510144X.
6
Response to Barner et al. (2025) on comment on Zabik et al. (2024): special considerations for cannabis research in RCTs and feasibility in a clinical setting.
Psychopharmacology (Berl). 2025 Aug 15. doi: 10.1007/s00213-025-06883-y.
7
Evidence on the effect of in-utero cannabis exposure in neonates.
J Perinatol. 2025 Aug 13. doi: 10.1038/s41372-025-02383-1.
8
Divergent outcomes of delta 9 - tetrahydrocannabinol (THC) in adolescence on mesocortical dopamine and cognitive development in male and female mice.
Psychopharmacology (Berl). 2025 Jul 14. doi: 10.1007/s00213-025-06791-1.
9
Pharmacokinetics of cannabidiol and its two main phase I metabolites in Connemara ponies.
Front Vet Sci. 2025 Jun 27;12:1599934. doi: 10.3389/fvets.2025.1599934. eCollection 2025.
10
Pharmacokinetics of Cannabidiol in Rat Brain Tissue After Single-Dose Administration of Different Formulations.
Molecules. 2025 Jun 20;30(13):2676. doi: 10.3390/molecules30132676.
本文引用的文献
1
Detection of THCA in oral fluid by GC-MS-MS.
J Anal Toxicol. 2006 Nov-Dec;30(9):645-50. doi: 10.1093/jat/30.9.645.
2
Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device.
J Anal Toxicol. 2006 Oct;30(8):614-6. doi: 10.1093/jat/30.8.614.
3
Cannabinoid concentrations in hair from documented cannabis users.
Forensic Sci Int. 2007 Jul 4;169(2-3):129-36. doi: 10.1016/j.forsciint.2006.08.005. Epub 2006 Sep 11.
4
Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays.
J Anal Toxicol. 2006 Sep;30(7):413-8. doi: 10.1093/jat/30.7.413.
5
Analytical procedure for the determination of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens.
J Anal Toxicol. 2006 Sep;30(7):409-12. doi: 10.1093/jat/30.7.409.
6
Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
Ther Drug Monit. 2006 Aug;28(4):545-51. doi: 10.1097/00007691-200608000-00010.
7
Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues.
Forensic Sci Int. 2006 Sep 12;161(2-3):169-74. doi: 10.1016/j.forsciint.2006.04.018. Epub 2006 Jul 21.
8
Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.
Forensic Sci Int. 2006 Sep 12;161(2-3):175-9. doi: 10.1016/j.forsciint.2006.03.033. Epub 2006 Jul 13.
9
Application of two-dimensional gas chromatography with electron capture chemical ionization mass spectrometry to the detection of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair.
J Anal Toxicol. 2006 Apr;30(3):171-7. doi: 10.1093/jat/30.3.171.
10
Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
J Anal Toxicol. 2005 Oct;29(7):607-15. doi: 10.1093/jat/29.7.607.
Zotero 插件